New HIV-1 prodrug shows promise in phase III trials

被引：0
|
作者：
Louise Stone
机构：
来源：
Nature Reviews Urology | 2015年 / 12卷 / 6期
关键词：
D O I：
10.1038/nrurol.2015.96
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 301
相关论文
共 50 条
  • [21] The promise of CCR5 antagonists as new therapies for HIV-1
    Repik, Alexander
    Richards, Kathryn H.
    Clapham, Paul R.
    [J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (02) : 130 - 139
  • [22] Model based design and analysis of phase II HIV-1 trials
    Dinko Rekić
    Daniel Röshammar
    Ulrika S. H. Simonsson
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 487 - 496
  • [23] Model based design and analysis of phase II HIV-1 trials
    Rekic, Dinko
    Roshammar, Daniel
    Simonsson, Ulrika S. H.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (04) : 487 - 496
  • [24] HIV-1 coreceptors: From discovery and designation to new paradigms and promise - Preface
    Gresser, Ursula
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 369 - 369
  • [25] Primary HIV-1 resistance - A new phase in the epidemic?
    Pomerantz, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12): : 1177 - 1179
  • [26] Surrogacy in HIV-1 clinical trials
    Pozniak, A
    [J]. LANCET, 1998, 351 (9102): : 536 - 537
  • [27] Human trials of HIV-1 vaccines
    Mulligan, MJ
    Weber, J
    [J]. AIDS, 1999, 13 : S105 - S112
  • [28] BLYS-targeted antibody shows promise in Phase III SLE trial
    [J]. Nature Reviews Drug Discovery, 2009, 8 : 688 - 688
  • [29] BLYS-targeted antibody shows promise in Phase III SLE trial
    不详
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) : 688 - 688
  • [30] HIV-1 Shows Increased Sensitivity to Griffithsin Derivatives
    Alexandre, Kabamba Bankoledi
    Buckheit, Karen W.
    Haugh-Krumpe, Lauren
    Constantine, Brian
    Buckheit, Robert W.
    O'Keefe, Barry R.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A203 - A203
12345